POU2AF1 anticorps (AA 148-255)

N° du produit ABIN7870759

Cet anticorps anti-POU2AF1 Monoclonal Souris (Clone BOB1-7467) (ABIN7870759) détecte spécifiquement POU2AF1 dans IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour POU2AF1 anticorps (AA 148-255) (ABIN7870759)

Antigène: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp POU2AF1 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: BOB1-7467

Détail du produit anti-POU2AF1 anticorps

Épitope: AA 148-255

Fonction: BOB-1 Antibody / POU2AF1 (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: A recombinant partial protein (within amino acids 148-255) from the human protein was used as the immunogen for the BOB-1 antibody.

Isotype: IgG2, kappa

Information d'application

Indications d'application: Optimal dilution of the BOB-1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the BOB-1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur POU2AF1

Antigène: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Autre désignation: BOB-1

Sujet: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.

UniProt: Q16633